Obscurins: Unassuming giants enter the spotlight

IUBMB Life

Volumn 65, Issue 6, 2013, Pages 479-486

  Perry, Nicole A ^a   Ackermann, Maegen A ^a   Shriver, Marey ^a   Hu, Li Yen R ^a   Kontrogianni Konstantopoulos, Aikaterini ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Cardiac hypertrophy; OBSCN; Obscurin; Striated muscle; UNC 89

Indexed keywords

OBSCURIN;

CELLULAR DISTRIBUTION; DISEASE COURSE; EMBRYO DEVELOPMENT; GENE; GENETIC LINKAGE; HEART MUSCLE; HEART VENTRICLE HYPERTROPHY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR PATHOLOGY; MUSCLE FIBRIL; NONHUMAN; OBSCN GENE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

BREAST CANCER; CARDIAC HYPERTROPHY; OBSCN; OBSCURIN; STRIATED MUSCLE; UNC-89;

ANIMALS; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; HUMANS; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MUTATION, MISSENSE; NEOPLASMS; ORGAN SPECIFICITY; PROTEIN INTERACTION MAPS; RHO GUANINE NUCLEOTIDE EXCHANGE FACTORS;

EID: 84881499109     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1157     Document Type: Review

References (64)

1. Young, P., Ehler, E., and Gautel, M. (2001) Obscurin, a giant sarcomeric Rho guanine nucleotide exchange factor protein involved in sarcomere assembly. J. Cell. Biol. 154, 123-136.
2. Russell, M. W., Raeker, M. O., Korytkowski, K. A., and Sonneman, K. J. (2002) Identification, tissue expression and chromosomal localization of human Obscurin-MLCK, a member of the titin and Dbl families of myosin light chain kinases. Gene 282, 237-246.
3. Fukuzawa, A., Idowu, S., and Gautel, M. (2005) Complete human gene structure of obscurin: implications for isoform generation by differential splicing. J. Muscle Res. Cell Motil. 26, 427-434.
4. Borisov, A. B., Raeker, M. O., and Russell, M. W. (2008) Developmental expression and differential cellular localization of obscurin and obscurin-Associated kinase in cardiac muscle cells. J. Cell. Biochem. 103, 1621-1635.
5. Lange, S., Ouyang, K., Meyer, G., Cui, L., Cheng, H., et al. (2009) Obscurin determines the architecture of the longitudinal sarcoplasmic reticulum. J. Cell Sci. 122, 2640-2650.
6. Kontrogianni-Konstantopoulos, A. and Bloch, R.J. (2005) Obscurin: a multitasking muscle giant. J. Muscle Res. Cell Motil. 26, 419-426.
7. Perry, N. A., Shriver, M., Mameza, M. G., Grabias, B., Balzer, E., et al. (2012) Loss of giant obscurins promotes breast epithelial cell survival through apoptotic resistance. FASEB J. 26, 2764-2775.
8. Bowman, A. L., Kontrogianni-Konstantopoulos, A., Hirsch, S. S., Geisler, S. B., Gonzalez-Serratos, H., et al. (2007) Different obscurin isoforms localize to distinct sites at sarcomeres. FEBS Lett. 581, 1549-1554.
9. Sutter, S. B., Raeker, M. O., Borisov, A. B., and Russell, M. W. (2004) Orthologous relationship of obscurin and Unc-89: phylogeny of a novel family of tandem myosin light chain kinases. Dev. Genes Evol. 214, 352-359.
10. Benian, G. M., Tinley, T. L., Tang, X., and Borodovsky, M. (1996) The Caenorhabditis elegans gene unc-89, required fpr muscle M-line assembly, encodes a giant modular protein composed of Ig and signal transduction domains. J. Cell Biol. 132, 835-848.
11. Small, T. M., Gernert, K. M., Flaherty D. B., Mercer K. B., Borodovsky M., et al. (2004) Three new isoforms of Caenorhabditis elegans UNC-89 containing MLCK-like protein kinase domains. J. Mol. Biol. 342, 91-108.
12. Ferrara, T. M., Flaherty, D. B., and Benian, G. M. (2005) Titin/connectin-related proteins in C. elegans: a review and new findings. J. Muscle Res. Cell Motil. 26, 435-447.
13. Blomberg, N., Baraldi, E., Sattler, M., Saraste, M., and Nilges, M. (2000) Structure of a PH domain from the C. elegans muscle protein UNC-89 suggests a novel function. Structure 8, 1079-1087.
14. Qadota, H., Blangy, A., Xiong, G., and Benian, G. M. (2008) The DH-PH region of the giant protein UNC-89 activates RHO-1 GTPase in Caenorhabditis elegans body wall muscle. J. Mol. Biol. 383, 747-752.
15. Qadota, H., McGaha, L. A., Mercer, K. B., Stark, T. J., Ferrara, T. M., et al. (2008) A novel protein phosphatase is a binding partner for the protein kinase domains of UNC-89 (Obscurin) in Caenorhabditis elegans. Mol. Biol. Cell 19, 2424-2432.
16. Xiong, G., Qadota, H., Mercer, K. B., McGaha, L. A., Oberhauser, A. F., et al. (2009) A LIM-9 (FHL)/SCPL-1 (SCP) complex interacts with the C-Terminal protein kinase regions of UNC-89 (obscurin) in Caenorhabditis elegans muscle. J. Mol. Biol. 386, 976-988.
17. Spooner, P. M., Bonner, J., Maricq, A. V., Benian, G. M., and Norman, K. R. (2012) Large isoforms of UNC-89 (obscurin) are required for muscle cell architecture and optimal calcium release in Caenorhabditis elegans. PLoS One 7, e40182.
18. Wilson, K. J., Qadota, H., Mains, P. E., and Benian, G. M. (2012) UNC-89 (obscurin) binds to MEL-26, a BTB-domain protein, and affects the function of MEI-1 (katanin) in striated muscle of Caenorhabditis elegans. Mol. Biol. Cell 23, 2623-2634.
19. Warner, A., Xiong, G., Qadota, H., Rogalski, J., Vogl, A. W., Moerman, D. G., Benian, G. M. CPNA-1, a copine domain protein, is located at integrin adhesion sites, and is required for myofilament stability in C. elegans. Mol Biol Cell. 2013. Jan 2. Epub ahead of print
20. Raeker, M. O., Su, F., Geisler, S. B., Borisov, A. B., Kontrogianni-Konstantopoulos, A., et al. (2006) Obscurin is required for the lateral alignment of striated myofibrils in zebrafish. Dev. Dyn. 235, 2018-2029.
21. Raeker, M. O., Bieniek, A. N., Ryan, A. S., Tsai, H. J., Zahn, K. M., et al. (2010) Targeted deletion of the zebrafish obscurin A RhoGEF domain affects heart, skeletal muscle and brain development. Dev. Biol. 337, 432-443.
22. Raeker, M. O. and Russell, M. W. (2011) Obscurin depletion impairs organization of skeletal muscle in developing zebrafish embryos. J. Biomed. Biotechnol. 2011, 479135.
23. Katzemich, A., Kreiskother, N., Alexandrovich, A., Elliott, C., Schock, F., et al. (2012) The function of the M-line protein obscurin in controlling the symmetry of the sarcomere in the flight muscle of Drosophila. J. Cell. Sci. 125, 3367-3379.
24. Hsieh, C. M., Fukumoto, S., Layne, M. D., Maemura, K., Charles, H., et al. (2000) Striated muscle preferentially expressed genes alpha and beta are two serine/threonine protein kinases derived from the same gene as the aortic preferentially expressed gene-1. J. Biol. Chem. 275, 36966-36973.
25. Geisler, S. B., Robinson, D., Hauringa, M., Raeker, M. O., Borisov, A. B., et al. (2007) Obscurin-like 1, OBSL1, is a novel cytoskeletal protein related to obscurin. Genomics 89, 521-531.
26. Kontrogianni-Konstantopoulos, A., Ackermann, M. A., Bowman, A. L., Yap, S. V., and Bloch, R. J. (2009) Muscle giants: molecular scaffolds in sarcomerogenesis. Physiol. Rev. 89, 1217-1267.
27. Spudich, J. A. (2001) The myosin swinging cross-bridge model. Nat. Rev. Mol. Cell Biol. 2, 387-392.
28. Carlsson, L., Yu, J. G., and Thornell, L. E. (2008) New aspects of obscurin in human striated muscles. Histochem. Cell Biol. 130, 91-103.
29. Kontrogianni-Konstantopoulos, A., Jones, E. M., Van Rossum, D. B., and Bloch, R. J. (2003) Obscurin is a ligand for small ankyrin 1 in skeletal muscle. Mol. Biol. Cell 14, 1138-1148.
30. Borisov, A. B., Martynova, M. G., and Russell, M. W. (2008) Early incorporation of obscurin into nascent sarcomeres: implication for myofibril assembly during cardiac myogenesis. Histochem. Cell Biol. 129, 463-478.
31. Hu, L.-Y. and Kontrogianni-Konstantopoulos, A. (2013) The kinase domains of obscurin interact with intercellular adhesion proteins. FASEB J., ePublication date February 7, 2013.
32. Kontrogianni-Konstantopoulos, A., Catino, D. H., Strong, J. C., and Bloch, R. J. (2006) De novo myofibrillogenesis in C2C12 cells: evidence for the independent assembly ofM bands and Z disks. Am. J. Physiol. Cell Physiol. 290, C626-637.
33. Bang, M. L., Centner, T., Fornoff, F., Geach, A. J., Gotthardt, M., et al. (2001) The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system. Circ. Res. 89, 1065-1072.
34. Fukuzawa, A., Lange, S., Holt, M., Vihola, A., Carmignac, V., et al. (2008) Interactions with titin and myomesin target obscurin and obscurin-like 1 to the M-band: implications for hereditary myopathies. J. Cell Sci. 121, 1841-1851.
35. Pernigo, S., Fukuzawa, A., Bertz, M., Holt, M., Rief, M., et al. (2010) Structural insight into M-band assembly and mechanics from the titin-obscurin-like-1 complex. Proc. Natl. Acad. Sci. USA 107, 2908-2913.
36. Ackermann, M. A., Hu, L. Y., Bowman, A. L., Bloch, R. J., and Kontrogianni-Konstantopoulos, A. (2009) Obscurin interacts with a novel isoform of MyBP-C slow at the periphery of the sarcomeric M-band and regulates thick filament assembly. Mol. Biol. Cell 20, 2963-2978.
37. Lange, S., Perera, S., Teh, P., and Chen, J. (2012) Obscurin and KCTD6 regulate cullin-dependent small ankyrin-1 (sAnk1.5) protein turnover. Mol. Biol. Cell 23, 2490-2504.
38. Ford-Speelman, D. L., Roche, J. A., Bowman, A. L., and Bloch, R. J. (2009) The rho-guanine nucleotide exchange factor domain of obscurin activates rhoA signaling in skeletal muscle. Mol. Biol. Cell 20, 3905-3917.
39. Coisy-Quivy, M., Touzet, O., Bourret, A., Hipskind, R. A., Mercier, J., et al. (2009) TC10 controls human myofibril organization and is activated by the sarcomeric RhoGEF obscurin. J. Cell Sci. 122, 947-956.
40. Sah, V. P., Hoshijima, M., Chien, K. R., and Brown, J. H. (1996) Rho is required for Galphaq and alpha1-Adrenergic receptor signaling in cardiomyocytes. Dissociation of Ras and Rho pathways. J. Biol. Chem. 271, 31185-31190.
41. Borisov, A. B., Raeker, M. O., Kontrogianni-Konstantopoulos, A., Yang, K., Kurnit, D. M., et al. (2003) Rapid response of cardiac obscurin gene cluster to aortic stenosis: differential activation of Rho-GEF and MLCK and involvement in hypertrophic growth. Biochem. Biophys. Res. Commun. 310, 910-918.
42. Wu, Y., Bell, S. P., Trombitas, K., Witt, C. C., Labeit, S., et al. (2002) Changes in titin isoform expression in pacinginduced cardiac failure give rise to increased passive muscle stiffness. Circulation 106, 1384-1389.
43. Bishop, A. L. and Hall, A. (2000) Rho GTPases and their effector proteins. Biochem. J. 348 Pt 2, 241-255.
44. Bowman, A. L., Catino, D. H., Strong, J. C., Randall, W. R., Kontrogianni-Konstantopoulos, A., et al. (2008) The rho-guanine nucleotide exchange factor domain of obscurin regulates assembly of titin at the Z-disk through interactions with Ran binding protein 9.Mol. Biol. Cell 19, 3782-3792.
45. Bagnato, P., Barone, V., Giacomello, E., Rossi, D., and Sorrentino, V. (2003) Binding of an ankyrin-1 isoform to obscurin suggests a molecular link between the sarcoplasmic reticulum and myofibrils in striated muscles. J. Cell Biol. 160, 245-253.
46. Busby, B., Willis, C. D., Ackermann, M. A., Kontrogianni-Konstantopoulos, A., and Bloch, R. J. (2010) Characterization and comparison of two binding sites on obscurin for small ankyrin 1. Biochemistry 49, 9948-9956.
47. Borzok, M. A., Catino, D. H., Nicholson, J. D., Kontrogianni- Konstantopoulos, A., and Bloch R. J. (2007) Mapping the binding site on small ankyrin 1 for obscurin. J. Biol. Chem. 282, 32384-32396.
48. Busby, B., Oashi, T., Willis, C. D., Ackermann, M. A., Kontrogianni-Konstantopoulos, A., et al. (2011) Electrostatic interactions mediate binding of obscurin to small ankyrin 1: biochemical and molecular modeling studies. J. Mol. Biol. 408, 321-334.
49. Willis, C. D., Oashi, T., Busby, B., Mackerell, A. D., Jr., and Bloch R. J. (2012) Hydrophobic residues in small ankyrin 1 participate in binding to obscurin. Mol. Membr. Biol. 29, 36-51.
50. Armani, A., Galli, S., Giacomello, E., Bagnato, P., Barone, V., et al. (2006) Molecular interactions with obscurin are involved in the localization of muscle-specific small ankyrin1 isoforms to subcompartments of the sarcoplasmic reticulum. Exp. Cell Res. 312, 3546-3558.
51. Cunha, S. R. and Mohler, P. J. (2008) Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac Mline. J. Biol. Chem. 283, 31968-31980.
52. Kontrogianni-Konstantopoulos, A., Catino, D. H., Strong, J. C., Sutter, S., Borisov, A. B., et al. (2006) Obscurin modulates the assembly and organization of sarcomeres and the sarcoplasmic reticulum. FASEB J. 20, 2102-2111.
53. Waterston, R. H., Thomson, J. N., and Brenner, S. (1980) Mutants with altered muscle structure of Caenorhabditis elegans. Dev. Biol. 77, 271-302.
54. Nagase, T., Kikuno, R., Nakayama, M., Hirosawa, M., and Ohara, O. (2000) Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res. 7, 273-281.
55. Arimura, T., Matsumoto, Y., Okazaki, O., Hayashi, T., Takahashi, M., et al. (2007) Structural analysis of obscurin gene in hypertrophic cardiomyopathy. Biochem. Biophys. Res. Commun. 362, 281-287.
56. Ghahramani Seno, M. M., Trollet, C., Athanasopoulos, T., Graham, I. R., Hu, P., et al. (2010) Transcriptomic analysis of dystrophin RNAi knockdown reveals a central role for dystrophin in muscle differentiation and contractile apparatus organization. BMC Genomics 11, 345.
57. Makarenko, I., Opitz, C. A., Leake, M. C., Neagoe, C., Kulke, M., et al. (2004) Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts. Circ. Res. 95, 708-716.
58. Borisov, A. B., Sutter, S. B., Kontrogianni-Konstantopoulos, A., Bloch, R. J., Westfall, M. V., et al. (2006) Essential role of obscurin in cardiac myofibrillogenesis and hypertrophic response: evidence from small interfering RNAmediated gene silencing. Histochem. Cell Biol. 125, 227-238.
59. Sjoblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., et al. (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314, 268-274.
60. Balakrishnan, A., Bleeker, F. E., Lamba, S., Rodolfo, M., Daniotti, M., et al. (2007) Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma. Cancer Res. 67, 3545-3550.
61. Vernon, E. G., Malik, K., Reynolds, P., Powlesland, R., Dallosso, A. R., et al. (2003) The parathyroid hormone-responsive B1 gene is interrupted by a t(1;7)(q42;p15) breakpoint associated with Wilms' tumour. Oncogene 22, 1371-1380.
62. Price, N. D., Trent, J., El-Naggar, A. K., Cogdell, D., Taylor, E., et al. (2007) Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas. Proc. Natl. Acad. Sci. USA 104, 3414-3419.
63. Kim, J. H., Park, B. L., Pasaje, C. F., Kim, Y., Bae, J. S., et al. (2010) Contribution of the OBSCN nonsynonymous variants to aspirin exacerbated respiratory disease susceptibility in Korean population. DNA Cell Biol. 31, 1001-1009.
64. Kho, A. L., Perera, S., Alexandrovich, A., and Gautel, M. (2012) The sarcomeric cytoskeleton as a target for pharmacological intervention. Curr. Opin. Pharmacol. 12, 347-354.